These findings highlight the potential of DCL as a promising therapeutic candidate for renal fibrosis, providing novel insights into the IQGAP1-CCT3-Wnt signaling axis as a potential target for renal fibrosis intervention. Here, CCT3 is linked to renal fibrosis.